Trials / Completed
CompletedNCT00551616
Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,221 (actual)
- Sponsor
- HRA Pharma · Industry
- Sex
- Female
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of CDB-2914 in comparison to levonorgestrel for preventing pregnancy up to 5 days after unprotected sexual intercourse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CDB-2914 | Single dose |
| DRUG | Levonorgestrel | Single dose |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2007-10-31
- Last updated
- 2022-05-03
- Results posted
- 2022-03-16
Locations
33 sites across 3 countries: United States, Ireland, United Kingdom
Source: ClinicalTrials.gov record NCT00551616. Inclusion in this directory is not an endorsement.